# Targeting Tris(2,3-dibromopropyl) Isocyanurate-Induced Inflammation in Hippocampal Neurons In Vitro: Mechanistic Insights and Implications for Neurodegenerative Disease Prevention

**Authors:** Dominika Szlachcikowska, Oliwia Koszła, Przemysław Sołek, Anna Tabęcka-Łonczyńska

PMC · DOI: 10.1007/s12035-025-05301-w · 2025-11-19

## TL;DR

This study explores how TBC, an environmental contaminant, harms hippocampal neurons and contributes to neurodegenerative diseases through inflammation and oxidative stress.

## Contribution

The study reveals that TBC induces neurotoxicity via NF-κB signaling and oxidative stress pathways in hippocampal neurons.

## Key findings

- TBC at higher concentrations reduces metabolic activity and increases apoptosis markers in hippocampal cells.
- TBC modulates NF-κB signaling and induces calcium release, contributing to neuroinflammation.
- Antioxidants and Keap1-Nrf2 pathway inhibitors reduce TBC-induced oxidative stress and inflammation.

## Abstract

Tris(2,3-dibromopropyl) isocyanurate (TBC) represents an emerging environmental contaminant with potential neurotoxic effects, attributable to its tendency to bioaccumulate and its capacity to traverse the blood–brain barrier. This study investigates the impact of TBC on cellular metabolism, membrane integrity or apoptosis-related caspase activity in mouse hippocampal cells, examining its interaction with key signaling pathways. Our results indicated that while TBC did not exhibit significant cytotoxicity at lower concentrations, prolonged exposure to higher concentrations substantially decreased metabolic activity and increased apoptotic marker activities (caspase-1, -3 and -9). Co-treatment with CAY10464 (AhR antagonist), GW9662 (PPARγ antagonist) and honokiol (NF-κB inhibitor) revealed that TBC significantly modulated NF-κB signaling, with notable reductions in AhR and IκBα protein expressions and altered levels of mTOR, NF-κB and p-IκBα proteins. Furthermore, TBC induced calcium release, supporting its role in neuroinflammatory responses. Moreover, TBC inhibited antioxidant enzyme activity and increased proinflammatory cytokine expression, implicating oxidative stress and inflammation in its neurotoxic effects. Antioxidants and Keap1-Nrf2 pathway inhibitors partially attenuated these responses, highlighting the role of oxidative stress pathways. These results suggest that prolonged TBC exposure may impair neuronal metabolism and activate apoptotic pathways, with NF-κB playing a pivotal role in mediating its neurotoxic effects.

The online version contains supplementary material available at 10.1007/s12035-025-05301-w.

## Linked entities

- **Genes:** AHR (aryl hydrocarbon receptor) [NCBI Gene 196], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551]
- **Proteins:** Caspase1 (caspase-1), Casp3 (caspase 3), Casp9 (caspase 9), AHR (aryl hydrocarbon receptor), PPARG (peroxisome proliferator activated receptor gamma), NFKB1 (nuclear factor kappa B subunit 1), NFKBIA (NFKB inhibitor alpha), MTOR (mechanistic target of rapamycin kinase), KEAP1 (kelch like ECH associated protein 1), GABPA (GA binding protein transcription factor subunit alpha)
- **Chemicals:** Tris(2,3-dibromopropyl) isocyanurate (PubChem CID 103634), CAY10464 (PubChem CID 10062125), GW9662 (PubChem CID 644213), honokiol (PubChem CID 72303)
- **Diseases:** neurodegenerative disease (MONDO:0005559)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}
- **Diseases:** neurotoxic (MESH:D020258), Neurodegenerative Disease (MESH:D019636), neuroinflammatory (MESH:D000090862), cytotoxicity (MESH:D064420), Inflammation (MESH:D007249)
- **Chemicals:** TBC (MESH:C541743), honokiol (MESH:C005499), CAY10464 (-), calcium (MESH:D002118), GW9662 (MESH:C457499)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12627138/full.md

---
Source: https://tomesphere.com/paper/PMC12627138